| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1097/TP.0B013E3181F09C89 |
| P698 | PubMed publication ID | 20703179 |
| P2093 | author name string | Zhang Ying | |
| Min-Qiang Lu | |||
| Ma Chao | |||
| Shi-Bin Xie | |||
| Jian-Yun Zhu | |||
| Li-Jiao Zeng | |||
| P2860 | cites work | Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B | Q28212394 |
| Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir | Q28364197 | ||
| Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B. | Q31417222 | ||
| Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up | Q31440594 | ||
| A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. | Q31921588 | ||
| Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation | Q33183104 | ||
| A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection | Q34716850 | ||
| Results of lamivudine trials in Asia | Q35621678 | ||
| Evolving strategies to prevent HBV recurrence. | Q35894616 | ||
| Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade | Q35924478 | ||
| Management of hepatitis B in liver transplant recipients | Q36980721 | ||
| Hepatitis B and liver transplantation: 2008 update | Q37279114 | ||
| Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy | Q38500910 | ||
| Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection | Q43672287 | ||
| Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis | Q43672289 | ||
| Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients | Q44675031 | ||
| Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years | Q44933483 | ||
| Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant | Q45160775 | ||
| Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study | Q46183727 | ||
| Long-term results after liver transplantation. | Q52922055 | ||
| Liver transplantation in European patients with the hepatitis B surface antigen | Q72623987 | ||
| Hepatitis B virus infection | Q73929492 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver transplantation | Q1368191 |
| orthotopic liver transplantation | Q106649759 | ||
| P304 | page(s) | 786-790 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow-up study | |
| P478 | volume | 90 |
| Q41516975 | ABO-incompatible liver transplantation for severe hepatitis B patients |
| Q83423194 | Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population |
| Q26830371 | Clinical utility of entecavir for chronic hepatitis B in Chinese patients |
| Q40588229 | Comparative efficacy of oral nucleotide analogues for the prophylaxis of hepatitis B virus recurrence after liver transplantation: a network meta-analysis. |
| Q64247252 | Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review |
| Q38006958 | Hepatitis B immune globulin in liver transplantation prophylaxis: an update |
| Q38058545 | High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review. |
| Q37982346 | Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation |
| Q42183838 | Long-term results of liver transplantation for over 60 years old patients with hepatitis B virus-related end-stage liver disease. |
| Q90517832 | Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation |
| Q42164812 | Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis? |
| Q92201473 | Prevention and risk factors of the HBV recurrence after orthotopic liver transplantation: 160 cases follow up study: Retraction |
| Q26781880 | Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New? |
| Q38514411 | Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin. |
| Q42217341 | Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation |
| Q99552130 | Significance of Hepatitis B Recurrence in Liver Transplantation Recipients |
| Q44324348 | Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients |
| Q38980903 | The Management of Hepatitis B in Liver Transplant Recipients |
| Q38125740 | Treatment of patients with HBV-related decompensated cirrhosis and liver transplanted patients. |
Search more.